M Inc. (headquartered in Minato-ku, Tokyo; CEO: Shin Mori), provider of the brain MRI-based AI analysis service 'MVision health (M Vision Health)', announces the implementation of a new feature on TheoOne, a personal brain health portal launched by Theoria Technologies Inc. (headquartered in Bunkyo-ku, Tokyo; CEO: Kohei Sakata), a 100% subsidiary of Eisai Co., Ltd. This feature allows users to link and view their MVision health result reports directly on TheoOne. The integration will initially be rolled out at select medical institutions, with plans to expand based on future developments.

This feature marks the first concrete initiative under the business partnership agreement signed by both companies in December 2025. By enabling users to view their MVision health results on TheoOne, individuals can now connect their brain analysis outcomes with personalized lifestyle improvement actions tailored to their daily routines.

Background of the Integration

### Realizing the Business Partnership — Integrating 'Understanding the Brain' with 'Changing Behavior' —

M provides MVision health, an AI-powered service that leverages brain MRI data from brain checkups to quantify and visualize brain atrophy and white matter lesions (vascular health). The service is currently available at over 400 medical facilities nationwide.

By simply uploading brain MRI images to the cloud, MVision health analyzes all 505 brain structures, quantifying and visualizing key dementia risk factors—brain atrophy and white matter lesions (cerebrovascular health)—and delivers easy-to-understand result reports to users. The system enables age-group comparisons based on over 30,000 brain checkup datasets and allows users to track annual changes in brain health through repeated checkups.

Meanwhile, Theoria Technologies, operating under the mission 'Transforming how we approach dementia through technology', has developed multiple products as part of the Eisai Group ecosystem, supporting users from dementia risk reduction to long-term care and coexistence.

In December 2025, both companies signed a business partnership agreement, united by the shared vision of creating a society where early detection of structural brain changes and proactive efforts to reduce cognitive decline risks become the norm. This integration represents the first major outcome of that partnership, combining M’s 'scientific evidence' with Theoria’s proven 'solution capabilities' in driving lifestyle improvements and behavioral change.

Overview of the Integration

TheoOne is a comprehensive portal service that visualizes brain health status and provides personalized recommendations and support for reducing risks and maintaining cognitive function. With this integration, MVision health users can now:

- View their MVision health result reports directly on TheoOne, improving post-checkup information access. - Receive more accurate, personalized behavioral support on TheoOne, tailored to their individual lifestyle and personal goals.

Previously, brain checkup results and lifestyle improvement efforts existed as isolated 'data points'. This integration creates a seamless experience by connecting them through TheoOne as a central hub.

Comment from Shin Mori, CEO of M Inc.

'Understanding one’s health and translating that knowledge into behavioral change is fundamental to preventive medicine. However, when it comes to brain health, few people truly understand their current condition.

With this integration, MVision health users can now experience a seamless journey: knowing their brain’s condition, clearly understanding what actions to take, and actually implementing those changes. Connecting scientific evidence from brain imaging to everyday life decisions—this is the social implementation M has always aimed for. We will continue to work with Theoria Technologies to realize a society where dementia prevention is the norm.'

About M Inc.

Founded by Shin Mori, a globally recognized expert in medical image analysis, M Inc. was established to fulfill the mission of bringing cutting-edge imaging research into real-world applications. Using AI at the highest research standards, the company extracts valuable health insights from medical images such as MRI and CT scans. 'MVision health (M Vision Health)', which quantifies and evaluates whole-brain atrophy and vascular health (white matter lesions), is available at over 400 health screening facilities nationwide and is rapidly expanding. Additionally, 'MVision body (M Vision Body)', which measures physical frailty factors such as visceral fat and muscle mass, was launched this year. M will continue to create and operate services that contribute to maintaining brain and body health, well-being, and extending healthy life expectancy. https://www.corporate-m.com/

FACT BOX

  • Source: PR TIMES
  • Category: Partnership
  • Products / services: MVision health